Neogen Chemicals (NEOGEN) Q3 24/25 earnings summary

Executive summary

• Q3 FY25 revenue grew 22% year-over-year to INR 201 crore, with EBITDA up 71% and PAT up 844%, driven by BuLi Chem integration, volume gains, and operational efficiencies.

• Amalgamation of BuLi Chemicals with the company effective January 31, 2025, streamlining operations and expanding product offerings.

• Successfully navigated a depressed pricing environment and global headwinds, aided by new product launches and export focus.

• Strategic shift to diversify end-use sectors, including semiconductors, flavors & fragrance, and custom synthesis, to offset agrochemical slowdown.

• Export sales contributed 27% in FY24, with key geographies including the USA, Europe, China, Korea, and Japan.

Financial highlights

• Consolidated Q3 FY25 revenue reached INR 201.43 crore (up 22% YoY); EBITDA rose 71% to INR 34.6 crore; PAT was INR 10.01 crore (up 844% YoY).

• 9M FY25 consolidated revenue: INR 574.74 crore (up 17% YoY); EBITDA: INR 99.9 crore (up 35% YoY); PAT: INR 32.42 crore (up 73% YoY).

• Standalone Q3 FY25 revenue: INR 200.41 crore; net profit: INR 14.41 crore; EPS: INR 5.46.

• Domestic-to-export revenue mix stood at 65:35 for the quarter.

• Working capital days and cash flow from operations showed substantial improvement over the previous period.

Outlook and guidance

• Confident in achieving FY26 standalone revenue guidance of INR 950–1,000 crore, with lithium salts and electrolytes as primary growth drivers beyond FY26.

• Battery chemicals revenue for FY25 expected at INR 20–30 crore due to delayed approvals, with FY26 guidance in the INR 300–500 crore range, depending on customer ramp-up and approvals.

• Greenfield battery materials facility on track for commissioning in H2 FY26, with majority of erection and engineering works complete.

• Peak revenue potential from battery materials expansion estimated at INR 2,500–2,950 crore, depending on lithium prices.

• TSM (contract manufacturing) business targeted to contribute 15–20% of revenue in FY26.